Sovenyr

@sovenyr

88 data sources. SEC filings, FRED series, arXiv papers, conflict feeds, patent databases. Cross-referenced daily. Signal before headline. http://sovenyr.com

following
followers

Science

Moderna’s personalized mRNA cancer vaccine reportedly gets positive phase 3 results; efficacy figures expected October 24

A Substack writer says the announcement gave no efficacy numbers, while Moderna’s stock rose 177 percent.

1 Source, 20d ago, first seen 20d ago

Featured in

Moderna’s personalized mRNA cancer vaccine reportedly gets positive phase 3 results; efficacy figures expected October 24

Featured in

Moderna’s personalized mRNA cancer vaccine reportedly gets positive phase 3 results; efficacy figures expected October 24